The Alkalizer Citrate Reduces Serum Uric Acid Levels and Improves Renal Function in Hyperuricemic Patients Treated with the Xanthine Oxidase Inhibitor Allopurinol
- 19 October 2010
- journal article
- research article
- Published by Taylor & Francis Ltd in Endocrine Research
- Vol. 35 (4), 145-154
- https://doi.org/10.3109/07435800.2010.497178
Abstract
Objective. Hyperuricemia, an integral component of metabolic syndrome, is a major health problem causing gout and renal damage. Urine alkalizers such as citrate preparations facilitate renal excretion of the uric acid, but its supportive effect on xanthine oxidase inhibitors has not been tested yet. We performed a randomized, prospective study of the effect of a combination of allopurinol and a citrate preparation on renal function in patients with hyperuricemia, employing 70 patients who had hyperuricemia with serum uric acid levels ≥7.0 mg/dL, or those diagnosed as having hyperuricemia in the past. Methods. They were randomly enrolled into two study groups: the allopurinol monotherapy (MT) group or combination treatment (CT) group with allopurinol and a citrate preparation. Allopurinol (100–200 mg/day) in the absence or presence of a citrate preparation (3 g/day) was administered for 12 weeks and levels of serum uric acid, its urinary clearance (Cua), and the renal glomerular filtration rates assessed with the creatinine clearance (Ccr) were evaluated before and after the treatment. Results. Serum levels of uric acid decreased significantly in both groups, whereas the change observed was much greater in CT group. Cua was significantly increased in CT group but not in MT group. Ccr was not altered in both groups in general, whereas it was significantly increased in a fraction of CT group with decreased renal function. Conclusions. These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates.Keywords
This publication has 36 references indexed in Scilit:
- Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFRKidney International, 2010
- Impact of Long-Term Potassium Citrate Therapy on Urinary Profiles and Recurrent Stone FormationJournal of Urology, 2009
- Elevated Uric Acid Increases the Risk for Kidney DiseaseJournal of the American Society of Nephrology, 2008
- Uric acid and the development of metabolic syndrome in women and menMetabolism, 2008
- Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid LevelAmerican Journal of Kidney Diseases, 2006
- The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistanceKidney International, 2004
- Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?Hypertension, 2003
- The Purine Path to ChemotherapyScience, 1989
- Renal impairment and gout.Annals Of The Rheumatic Diseases, 1980
- Drug Control of Gout and HyperuricaemiaDrugs, 1978